School of Medicine

Showing 1-2 of 2 Results

  • Aussama Nassar, MD, MSc,FACS, FRCSC

    Aussama Nassar, MD, MSc,FACS, FRCSC

    Clinical Associate Professor, Surgery - General Surgery

    BioDr. Nassar is board-certified in both General Surgery and Surgical Critical Care in the United States and Canada, underscoring his exceptional expertise in these fields. He holds a Master of Science in Health Science Education from McMaster University, Canada, further solidifying his strong academic foundation.

    Currently, Dr. Nassar serves as the inaugural Director of the Emergency General Surgery Service and the Director of the Surgical Critical Care Fellowship Program at Stanford University. He is also the founder and director of the Surgery Resident Coaching Program. With over 12 years of clinical and academic experience at premier tertiary care referral centers across North America, Dr. Nassar brings unparalleled knowledge and leadership to his roles.

    Dr. Nassar's clinical interests include trauma, acute care surgery, critical care, and a particular focus on abdominal wall reconstruction. As a dedicated clinician-educator, he is a certified simulation educator and serves as a course director for ATLS and ASSET programs. His research is centered on advancing surgical education, with an emphasis on fostering the development of non-technical skills in surgical training.

    In addition to his educational initiatives, Dr. Nassar is actively engaged in developing innovative assessment tools for surgical trainees and addressing burnout among physicians and healthcare professionals. With a strong national and international presence, Dr. Nassar continues to shape the future of surgical education and healthcare delivery through his leadership, research, and advocacy.

    • Contact Info
      Mail Code: 5641
  • Jeffrey Norton, MD

    Jeffrey Norton, MD

    Robert L. and Mary Ellenburg Professor of Surgery, Emeritus

    Current Research and Scholarly InterestsInterleukin-12 is a Th1 cytokine. It is important in the cell mediated immune response. We are investigating its role as an anti-tumor cytokine to augment the immune response against cancer. We are planning a human trial.